News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,421 Results
Type
Article (475)
Company Profile (3)
Press Release (4943)
Section
Business (1608)
Career Advice (34)
Deals (252)
Drug Development (390)
Employer Resources (2)
FDA (130)
Job Trends (242)
News (2424)
Policy (198)
Tag
Academia (43)
Alliances (421)
ALS (1)
Alzheimer's disease (4)
Approvals (135)
Artificial intelligence (4)
Autoimmune disease (1)
Automation (1)
Bankruptcy (4)
Best Places to Work (181)
BIOSECURE Act (1)
Biosimilars (1)
Bladder cancer (1)
Brain cancer (3)
Breast cancer (2)
Cancer (28)
Cardiovascular disease (1)
Career advice (29)
CAR-T (1)
Cell therapy (1)
Cervical cancer (1)
Clinical research (355)
Collaboration (10)
COVID-19 (18)
C-suite (13)
Cystic fibrosis (1)
Data (29)
Diabetes (3)
Diagnostics (27)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (1)
Duchenne muscular dystrophy (2)
Earnings (418)
Editorial (1)
Employer resources (3)
Events (735)
Executive appointments (13)
FDA (148)
Funding (27)
Gene therapy (4)
GLP-1 (9)
Government (42)
Healthcare (289)
HIV (1)
Immuno-oncology (2)
Infectious disease (21)
Intellectual property (2)
Interviews (11)
IPO (115)
Job creations (64)
Job search strategy (20)
JPM (4)
Labor market (1)
Layoffs (8)
Leadership (1)
Legal (31)
Liver cancer (2)
Longevity (2)
Lung cancer (13)
Lymphoma (1)
Machine learning (1)
Manufacturing (9)
MASH (12)
Medical device (149)
Medtech (149)
Mergers & acquisitions (134)
Metabolic disorders (17)
Neurodegenerative disease (2)
Neuroscience (12)
NextGen: Class of 2026 (119)
Non-profit (70)
Obesity (1)
Opinion (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (2)
Patient recruitment (2)
People (427)
Pharmaceutical (1)
Phase 1 (82)
Phase 2 (148)
Phase 3 (145)
Pipeline (43)
Policy (1)
Postmarket research (5)
Preclinical (27)
Press Release (1)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (2)
Real estate (211)
Regulatory (145)
Research institute (20)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (1)
Series A (4)
Series B (3)
Special edition (1)
Spinal muscular atrophy (2)
Startups (69)
Stomach cancer (2)
Supply chain (3)
Vaccines (3)
Venture capital (4)
Weight loss (1)
Worklife (2)
Date
Last 7 days (2)
Last 30 days (12)
Last 365 days (198)
2026 (13)
2025 (205)
2024 (240)
2023 (258)
2022 (360)
2021 (420)
2020 (487)
2019 (599)
2018 (466)
2017 (273)
2016 (345)
2015 (331)
2014 (230)
2013 (232)
2012 (180)
2011 (185)
2010 (152)
Location
Africa (12)
Alabama (2)
Arizona (1)
Asia (473)
Australia (61)
California (51)
Canada (19)
China (5)
Colorado (3)
Connecticut (5)
Europe (992)
Florida (5)
Georgia (2)
Illinois (9)
Indiana (2)
Japan (4)
Kentucky (1)
Louisiana (1)
Maryland (14)
Massachusetts (51)
Michigan (1)
Minnesota (1)
Nevada (2)
New Jersey (11)
New York (9)
North Carolina (5)
Northern California (25)
Ohio (2)
Pennsylvania (19)
Rhode Island (2)
South America (15)
Southern California (19)
Tennessee (2)
Texas (13)
United States (242)
Utah (3)
Virginia (3)
Washington D.C. (1)
Washington State (28)
Wisconsin (1)
5,421 Results for "vib".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UZLeuven and VIB-KU Leuven Announce First Patient Treated in Ground-Breaking Malignant Melanoma Study
March 31, 2025
·
4 min read
Business
Mestag Therapeutics and VIB enter into an exclusive partnership in oncology
Mestag Therapeutics and VIB announced entering into an agreement under which Mestag obtains the exclusive worldwide rights to research, develop and commercialize a panel of single domain antibodies, also known as Nanobodies®, to an undisclosed target that plays a central role in anti-cancer immunity.
June 27, 2023
·
3 min read
Genetown
Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIB
Oxurion NV announced that it received approximately $400,000 in an upfront payment following the exercise of an option by a third party to license a preclinical oncology asset previously owned by its subsidiary, Oncurious, which had recently been transferred to VIB.
July 25, 2023
·
4 min read
Press Releases
Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
January 12, 2026
·
5 min read
Business
VIB and Surface Oncology Announce Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388
VIB, Flanders’ leading life sciences institute, and Surface Oncology today announced jointly the publication of a study entitled, “Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27: Cell Reports,” in Cell Reports, a leading scientific journal.
October 19, 2022
·
5 min read
Drug Development
ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19
ExeVir Bio announced the publication of a pre-print paper by De Cae et al., entitled “Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike”.
March 13, 2023
·
8 min read
Drug Development
Viela Bio Announces Final Results from Phase 1b Trial of VIB7734 in Patients with Cutaneous Lupus Erythematosus
VIB7734 potently depletedblood andtissue resident plasmacytoid dendritic cells, an important source of inflammatory mediators in autoimmune diseases
November 5, 2020
·
6 min read
VIB works on antiviral drug aimed to halt coronavirus outbreak
As the outbreak of the new coronavirus continues to spread, VIB scientists are quickly mobilizing to try to find a potential treatment for the viral infection.
February 12, 2020
·
5 min read
Press Releases
Syncell Expands European Market Presence to Advance Disease Research and Drug Discovery
October 15, 2025
·
3 min read
VIB achieves important milestone in the development of a COVID-19 drug
Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). The antibody was developed in collaboration with two research groups in the US.
March 17, 2020
·
5 min read
1 of 543
Next
